1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Pancreas Adenocarcinoma: new trials by email Literature Review of Pancreas Adenocarcinoma trials Research Report on Pancreas Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer Neoadjuvant chemotherapy, Upfront Surgery Group - Pancreas Cancer, Periampullary Cancer | Phase 3 | Recruiting | Minia University | 262 | 2025-07-20 | 2026-09-11 |
| Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) NovoTTF-200T, Gemcitabine, nab paclitaxel - Pancreas Adenocarcinoma | Phase 3 | Completed | NovoCure Ltd. | 571 | 2018-05-10 | 2026-01-21 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pancreatic Diseases (1)
Gemcitabine (1) · Neoadjuvant Therapy (1) · Taxes (1)
Minia University (1) · NovoCure Ltd. (1)
Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · Croatia (1) · Czechia (1) · Egypt (1) · France (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Israel (1) · Italy (1)